# Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy

> **NCT03366571** · — · UNKNOWN · sponsor: **Beijing Friendship Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** Nucleos(t)ide Analogues

## Key facts

- **NCT ID:** NCT03366571
- **Lead sponsor:** Beijing Friendship Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2023-12
- **Final completion:** 2024-12
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2021-04-14

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03366571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03366571, "Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03366571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*